...[Interpreted] Ladies and gentlemen, good afternoon. I bring the Annual General Meeting of Sanofi to order, a meeting which I'm honored to chair. After 2 years during which the world was faced with an unprecedented health crisis, which forced us to hold our Annual General Meeting virtually without your physical presence, we are immensely pleased to welcome you, once again, in-person and to discuss with you. I would like to thank all the shareholders who have cast their votes remotely before the meeting and all those who are currently following the live stream of the meeting. The recording will remain accessible on the Internet after the broadcast. By my side, I have Paul Hudson, CEO; Jean-Baptiste de Chatillon, CFO; and Philippe Peyre, General Secretary. We also have with us, and they are going to speak from the lectern, Patrick Kron, Chairman of the Remuneration Committee; John Reed, EVP for R&D; and Sandrine Bouttier-Stref, Head of CSR. We are now going to appoint the bureau of the meeting....
